Mesenchymal Stem Cell Exosomes Encapsulated Oral Microcapsules for Acute Colitis Treatment

Jingjing Gan,Lingyu Sun,Guopu Chen,Wenjuan Ma,Yuanjin Zhao,Lingyun Sun

DOI: https://doi.org/10.1002/adhm.202201105

IF: 10

2022-06-30

Advanced Healthcare Materials

Abstract:Mesenchymal stem cells derived‐exosomes (MSC‐exos) exhibit an intrinsic and directed efficiency for multiple diseases, while their versatile and effective delivery to the target site is still challenge. Herein, inspired by the acids and enzymes resistant property of sealing gelatin capsules, we present novel MSC‐exo‐encapsulated oral microcapsules for colitis treatment. Based on a microfluidic electrospray technique, MSC‐exos were first encapsulated in sodium alginate (SA) hydrogel microspheres with sustainable bioactivity. The resultant SA microspheres were then coated with a middle gelatin layer to protect MSC‐exos from degradation under an acid and enzymic environment. Especially, with an enteric coating‐Eudragit FS30D (EFS) on the outer layer, the resistance of the microcapsules in gastric juice was further enhanced. We have demonstrated that the prepared microcapsules could maintain the stability and bioactivity of the MSC‐exos during storage, protect them from the harsh conditions in the gastrointestinal tract (GIT), and enable the release of actives in the suitable sites for exerting their biological functions. In addition, these MSC‐exos encapsulated microcapsules could reduce the pro‐inflammatory cytokines levels of inflammatory macrophages and impaired colonic epithelial cells, which exhibit superior damage repair ability in injured colon sites during the treatment of colitis models. Thus, we believe that the proposed oral MSC‐exos encapsulated microcapsules are valuable for many practically clinical treatments. This article is protected by copyright. All rights reserved

nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials